Financial results - GB SOFT BIOTECH S.R.L.

Financial Summary - Gb Soft Biotech S.r.l.
Unique identification code: 39833405
Registration number: J2020001161052
Nace: 4312
Sales - Ron
134.379
Net Profit - Ron
5.282
Employees
10
Open Account
Company Gb Soft Biotech S.r.l. with Fiscal Code 39833405 recorded a turnover of 2024 of 134.379, with a net profit of 5.282 and having an average number of employees of 10. The company operates in the field of Lucrări de pregătire a terenului having the NACE code 4312.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Gb Soft Biotech S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 0 0 3.101 86.283 100.062 171.416 134.379
Total Income - EUR - - - 0 0 3.101 121.849 143.186 197.580 197.873
Total Expenses - EUR - - - 496 50 2.931 101.347 127.733 182.314 191.611
Gross Profit/Loss - EUR - - - -496 -50 170 20.502 15.454 15.266 6.262
Net Profit/Loss - EUR - - - -496 -50 139 19.656 14.603 13.809 5.282
Employees - - - 0 0 2 9 11 13 10
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -21.2%, from 171.416 euro in the year 2023, to 134.379 euro in 2024. The Net Profit decreased by -8.450 euro, from 13.809 euro in 2023, to 5.282 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Gb Soft Biotech S.r.l.

Rating financiar

Financial Rating -
GB SOFT BIOTECH S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Gb Soft Biotech S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Gb Soft Biotech S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Gb Soft Biotech S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Gb Soft Biotech S.r.l. - CUI 39833405

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 0 2.006 108.441 110.285 98.356 73.099 123.118
Current Assets - - - 0 63 7.212 63.634 93.842 153.245 113.775
Inventories - - - 0 0 0 0 0 20.781 29.210
Receivables - - - 0 0 3.690 60.616 93.541 131.434 84.143
Cash - - - 0 63 3.522 3.019 301 1.030 422
Shareholders Funds - - - -453 -494 -342 19.322 33.133 46.841 23.290
Social Capital - - - 43 42 45 44 45 44 44
Debts - - - 453 2.564 115.995 131.571 153.424 179.503 213.604
Income in Advance - - - 0 0 0 23.027 5.641 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4312 - 4312"
CAEN Financial Year 812
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 113.775 euro in 2024 which includes Inventories of 29.210 euro, Receivables of 84.143 euro and cash availability of 422 euro.
The company's Equity was valued at 23.290 euro, while total Liabilities amounted to 213.604 euro. Equity decreased by -23.289 euro, from 46.841 euro in 2023, to 23.290 in 2024.

Risk Reports Prices

Reviews - Gb Soft Biotech S.r.l.

Comments - Gb Soft Biotech S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.